Cubist Pharmaceuticals, Inc. · Lexington, MA United States (NASDAQ: CBST)
| 65 Hayden Ave. | Phone: 781-860-8660 |
| Lexington, MA | Fax: 781-240-0256 |
| 02421 | |
| United States | 
Map This Company |
Cubist Pharmaceuticals, Inc. Rankings
| S&P 600 |
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Fighting infection is a modern art at Cubist Pharmaceuticals. The company is developing antimicrobial agents to treat drug-resistant infections, including methicillin-resistant Staphylococcus aureus (MRSA), typically found in hospitals and other health care institutions. Its flagship product Cubicin is an intravenous antibiotic that is FDA-approved to fight MRSA infections of the skin and blood. The drug has also received regulatory approval in Europe and a handful of non-European countries. Cubist also maintains a pipeline of candidates in various stages of clinical and pre-clinical development.
Cubist Pharmaceuticals, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: CBST Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 638 |
Executives
168 executives listed for Cubist Pharmaceuticals, Inc.'s Lexington, MA location.
| Chairman | Kenneth Bate | |
|---|---|---|
| President, CEO, and Director | Michael Bonney | |
| EVP and COO | Robert Perez |